.Viridian Therapeutics' period 3 thyroid eye disease (TED) clinical trial has reached its own primar...
.Along with a strong track record for pinpointing diamonds in the rough, Bain Financing Daily Life S...
.The recent selection to merge Genentech's 2 cancer teams was actually produced "scientific factors,...
.Terns Pharmaceuticals' choice to drop its own liver disease aspirations may however pay off, after ...
.Merck & Co.'s long-running initiative to land a hit on small cell lung cancer (SCLC) has actuall...
.Some clients along with non-small tissue lung cancer cells (NSCLC) have mutations in a genetics cal...
.MBX has expanded plans to absorb over $136 thousand from its own IPO as the biotech seeks to bring ...
.Relay Therapies has hammered its own survival target in a first-in-human bust cancer cells research...
.AstraZeneca has utilized expert system to formulate a special biomarker for its own Daiichi Sankyo-...
.AstraZeneca executives mention they are "not anxious" that the failure of tozorakimab in a period 2...